Contract facts
FederalALLSCRIPTS HEALTHCARE, LLC:1281677 [22-001458]2B PRECISE ANNUAL SUBSCRIPTION is a federal award for National Institutes Of Health - Cc held by Allscripts Healthcare, LLC. Estimated value $7.7M ($11M obligated). Current period of performance ends Sep 29, 2023. Last award drew 1 bidder. Place of performance: BETHESDA MD.
ALLSCRIPTS HEALTHCARE, LLC:1281677 [22-001458]2B PRECISE ANNUAL SUBSCRIPTION
Recompete timing
PublicCurrent PoP ended Sep 29, 2023 (1057 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordAllscripts Healthcare, LLC — $11.1M obligated across 77 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N90022F00004?
75N90022F00004 (Allscripts healthcare llc:1281677 [22-001458]2b) is a National Institutes Of Health - Cc award with a potential value of $7.7M, currently held by Allscripts Healthcare, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N90022F00004?
National Institutes Of Health - Cc awarded 75N90022F00004 to Allscripts Healthcare, LLC (potential $7.7M).
Who is the incumbent on 75N90022F00004?
Allscripts Healthcare, LLC is the incumbent with $11.1M across 77 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2023.
When does Allscripts Healthcare, LLC’s 75N90022F00004 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 29, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
